
Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot. It's not as strong as some of its two-shot rivals but still potentially helpful for a world in dire need of more doses.
from CBC | Health News https://ift.tt/39vgcnX
Aucun commentaire:
Enregistrer un commentaire